drugset / Trial / NCT07121959

A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)

NCT07121959

Phase 1 Completed 14 enrolled Merck Sharp & Dohme LLC
Non-randomizedCrossoverOpen-labelBasic science

Summary

The goal of this study is to learn how belzutifan (MK-6482) affects the levels of metformin in a healthy person's body over time. Researchers will study levels of metformin in the blood and urine in healthy volunteers after taking metformin alone (Period 1) and metformin with belzutifan (Period 2).

Timeline

Start
2025-08-18
Primary completion
2025-09-13
Completion
2025-09-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Belzutifan Small molecule Oral
Subject Metformin Small molecule Oral

Indications

No indication recorded.